Access 100+ pre-vetted partners in specialised domains
Injectables | Inhalation systems | Peptide therapies | Biosimilars
Tier-1 CROs with Phase I-IV capabilities
CDMOs with FDA/EMA-approved facilities
We collaborate exclusively with top-tier clinical research organizations (CROs) and partners who align with our rigorous standards:
Partners are evaluated based on long-term strategic vision, leadership and management strength, regulatory compliance history, and 5–10-year operational roadmaps.
Emphasis on proactive contingency planning, operational resilience, and uninterrupted service delivery across development programs. Primary focus is on regulatory compliance and timely delivery.
Collaborations with Global and Indian CROs in early phase and late phase development. Also, tie-up with CROs and CDMOs to support in-vitro studies.
We excel at transforming innovative concepts into market-ready therapeutics by applying a Quality by Design (QbD) approach and leveraging strategic partnerships. Our expertise spans diverse areas, including advanced nasal spray formulations for targeted drug delivery, optimized GLP-1 analogues for improved drug action in diabetology, and the development of safer, more effective hormonal contraceptives. By integrating cutting-edge analytical techniques with a deep understanding of global regulatory pathways, we accelerate the development of differentiated pharmaceutical products that address unmet medical needs and improve patient outcomes in key therapeutic areas such as psychiatry, respiratory, and oncology.
Effective auditing is critical for ensuring compliance with regulatory standards in the biopharma industry.
Our auditing services focus on identifying risks, streamlining processes, and enhancing operational efficiency. We help organizations adhere to GMP, GLP, and other industry standards while maintaining a proactive approach to quality assurance. By partnering with us, you can mitigate compliance risks and drive sustainable improvements. Trust us to safeguard your operations and ensure regulatory excellence.
KAAS BioPharma: Accelerating pharmaceutical innovation through GenAI-powered predictive modeling, strategic clinical development, regulatory excellence, and global partnership for impactful product development.
A 410, Shelton Sapphire, Plot no 18 & 19, Sector 15, CBD Belapur, Navi Mumbai, Maharashtra 400614
